Two Sigma Advisers
ALBO

Two Sigma Advisers’s Albireo Pharma Inc ALBO Stock Holding History

Two Sigma Advisers’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,000
Closed -$238K – 2826
2022
Q4 		$238K Sell
11,000
-900
-8% -$19K ﹤0.01% 2137
2022
Q3 		$230K Sell
11,900
-14,100
-54% -$292K ﹤0.01% 2158
2022
Q2 		$516K Sell
26,000
-18,200
-41% -$480K ﹤0.01% 1909
2022
Q1 		$1.32M Sell
44,200
-1,900
-4% -$55.6K ﹤0.01% 1484
2021
Q4 		$1.07M Sell
46,100
-24,800
-35% -$659K ﹤0.01% 1530
2021
Q3 		$2.21M Sell
70,900
-82,700
-54% -$2.56M 0.01% 1194
2021
Q2 		$5.4M Sell
153,600
-58,300
-28% -$1.9M 0.01% 830
2021
Q1 		$7.47M Buy
211,900
+10,200
+5% +$377K 0.02% 689
2020
Q4 		$7.57M Buy
201,700
+163,000
+421% +$5.93M 0.02% 667
2020
Q3 		$1.29M Buy
38,700
+17,100
+79% +$498K ﹤0.01% 1384
2020
Q2 		$572K Buy
21,600
+4,600
+27% +$109K ﹤0.01% 1833
2020
Q1 		$278K Buy
17,000
+6,700
+65% +$147K ﹤0.01% 2044
2019
Q4 		$262K Buy
+10,300
New +$206K ﹤0.01% 2105
2014
Q2 		– Sell
-670
Closed -$54K – 2763
2014
Q1 		$54K Sell
670
-113
-14% -$10.3K ﹤0.01% 2204
2013
Q4 		$54K Buy
+783
New +$57.4K ﹤0.01% 2241

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Advisers's ALBO Position: Q1 2023 in Review

Two Sigma Advisers sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 11,000 shares — an estimated $238K sold.

Two Sigma Advisers first reported a position in ALBO in Q4 2013 and held it in 15 quarters. The position peaked at $7.57M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Two Sigma Advisers reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 11,000 Albireo Pharma Inc shares in Q1 2023, an estimated $238K.
  • Two Sigma Advisers first reported a position in Albireo Pharma Inc in Q4 2013 and held it in 15 quarters.
  • Two Sigma Advisers's Albireo Pharma Inc position peaked at $7.57M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.